Studies have found that in renal cell carcinoma, which is prevalent in North America, the expression level of S100A11 is positively correlated to the degree of cancer progression and tumor size, and negatively correlated to the disease-free survival rate of patients (Gabril et al., 2016). The gene discussed is S100A11; the disease is neoplasm.